artemisinin has been researched along with 2019 Novel Coronavirus Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Nair, MS; Wang, M; Weathers, PJ | 1 |
| Hussain, A | 1 |
| Nabi, N; Saffeullah, P; Singh, S | 1 |
| Cheong, DHJ; Tan, DWS; Tran, T; Wong, FWS | 1 |
| Chen, YC; Cheng, BL; Fan, TT; Fang, XM; Su, F | 1 |
| Ajibola, O; Amambua-Ngwa, A; Awolola, ST; Idowu, ET; Omidiji, O; Tola, M | 1 |
| Fidock, DA; Huang, Y; Nair, MS; Polyak, SJ; Towler, MJ; Wagoner, J; Weathers, PJ | 1 |
4 review(s) available for artemisinin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Recent Trends on Production Sources, Biosynthesis Pathways and Antiviral Efficacies of Artemisinin: A Candidate Phytomedicine against SARS-CoV-2.
Topics: Antimalarials; Antiviral Agents; Artemisia; Artemisinins; COVID-19; SARS-CoV-2 | 2023 |
An updated review on distribution, biosynthesis and pharmacological effects of artemisinin: A wonder drug.
Topics: Antimalarials; Artemisia; Artemisia annua; Artemisinins; COVID-19; Malaria | 2023 |
Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases.
Topics: Antiviral Agents; Artemisinins; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Lung Diseases; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Application of Chinese Medicine in the Management of Critical Conditions: A Review on Sepsis.
Topics: Anti-Inflammatory Agents; Artemisinins; Astragalus propinquus; Berberine; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drugs, Chinese Herbal; Emodin; Humans; Immunologic Factors; Intensive Care Units; Intestinal Mucosa; Medicine, Chinese Traditional; Microcirculation; Pandemics; Permeability; Pneumonia, Viral; Rheum; Salvia miltiorrhiza; SARS-CoV-2; Sepsis | 2020 |
3 other study(ies) available for artemisinin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
SARS-CoV-2 omicron variants are susceptible in vitro to Artemisia annua hot water extracts.
Topics: Angiotensin-Converting Enzyme 2; Artemisia annua; Body Weight; COVID-19; Humans; SARS-CoV-2; Tea | 2023 |
Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Calcium-Transporting ATPases; Child; Child, Preschool; Coronavirus Infections; COVID-19; Drug Resistance; Female; Gene Expression; Genotype; Humans; Infant; Malaria, Falciparum; Membrane Transport Proteins; Middle Aged; Molecular Epidemiology; Multidrug Resistance-Associated Proteins; Mutation; Nigeria; Pandemics; Plasmodium falciparum; Pneumonia, Viral; Protozoan Proteins | 2020 |
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
Topics: Animals; Antiviral Agents; Artemisia annua; Artemisinins; Cell Line; Cell Line, Tumor; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Flavonoids; Humans; Plant Extracts; Plant Leaves; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vero Cells; Virus Replication | 2021 |